GUPEA >
Sahlgrenska Academy / Sahlgrenska akademin >
Institute of Neuroscience and Physiology / Inst för neurovetenskap och fysiologi >
Doctoral Theses / Doktorsavhandlingar Institutionen för neurovetenskap och fysiologi >

The postsynaptic protein neurogranin: a new item in the Alzheimer’s disease biomarker toolbox


Please use this identifier to cite or link to this item: http://hdl.handle.net/2077/58493

Files in This Item:

File Description SizeFormat
gupea_2077_58493_1.pdfThesis frame4741KbAdobe PDF
View/Open
gupea_2077_58493_2.pdfCover3347KbAdobe PDF
View/Open
gupea_2077_58493_3.pdfAbstract202KbAdobe PDF
View/Open
Title: The postsynaptic protein neurogranin: a new item in the Alzheimer’s disease biomarker toolbox
Authors: Kvartsberg, Hlin
E-mail: hlin.kvartsberg@neuro.gu.se
Issue Date: 13-Mar-2019
University: University of Gothenburg. Sahlgrenska Academy
Institution: Institute of Neuroscience and Physiology. Department of Psychiatry and Neurochemistry
Parts of work: I. Kvartsberg H, Duits FH, Ingelsson M, Andreasen N, Öhrfelt A, Andersson K, Brinkmalm G, Lannfelt L, Minthon L, Hansson O, Andreasson U, Teunissen CE, Scheltens P, Van der Flier WM, Zetterberg H, Portelius E, Blennow K. Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease. Alzheimer’s & Dementia 2015, 11(10):1180-90.
VIEW ARTICLE


II. Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, Kornhuber J, Hansson O, Minthon L, Spitzer P, Maler JM, Zetterberg H, Blennow K, Lewczuk P. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls. Alzheimer’s Research & Therapy 2015, 7(1):40.
VIEW ARTICLE


III. Portelius E, Olsson B, Höglund K, Cullen NC, Kvartsberg H, Andreasson U, Zetterberg H, Sandelius Å, Shaw LM, Lee VMY, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk DA, McCluskey L, Elman L, McBride J, Toledo JB, Trojanowski JQ, Blennow K. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. Acta Neuropathologica 2018, 136(3):363-376.
VIEW ARTICLE


IV. Kvartsberg H, Lashley T, Murray CE, Brinkmalm G, Cullen NC, Höglund K, Zetterberg H, Blennow K, Portelius E. The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease. Acta Neuropathologica 2019, 137(1):89-102.
VIEW ARTICLE

Date of Defence: 2019-04-12
Disputation: Fredagen den 12 april 2019, kl. 9.00, Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3, Göteborg
Degree: Doctor of Philosophy (Medicine)
Publication type: Doctoral thesis
Keywords: CSF
brain tissue
Alzheimer's disease
biomarker
neurogranin
Abstract: Alzheimer’s disease (AD) is the most common form of dementia affecting more than 50 million people worldwide today and is characterised by progressive cognitive decline. One of the earliest events in AD, which is also closely related to neuronal loss and the degree of dementia, is synaptic degeneration. The degree of dementia has been found to correlate better with synaptic loss compared to other neuropathological changes, such as plaques and tangles. Synaptic proteins are therefore highly suita... more
ISBN: 978-91-7833-318-9 (Book)
978-91-7833-319-6 (PDF)
URI: http://hdl.handle.net/2077/58493
Appears in Collections:Doctoral Theses from Sahlgrenska Academy
Doctoral Theses from University of Gothenburg / Doktorsavhandlingar från Göteborgs universitet
Doctoral Theses / Doktorsavhandlingar Institutionen för neurovetenskap och fysiologi

 

 

© Göteborgs universitet 2011